z-logo
open-access-imgOpen Access
Metabolic Syndrome: Synergistic Risks for Doxorubicin-Induced Cardiotoxicity
Author(s) -
Elise P. Gómez-Sánchez
Publication year - 2021
Publication title -
journal of cardiovascular pharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/fjc.0000000000001140
Subject(s) - cardiotoxicity , doxorubicin , oxidative stress , medicine , lipid peroxidation , pharmacology , metabolic syndrome , endocrinology , dyslipidemia , toxicity , chemotherapy , disease , obesity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here